Nantong Jinghua Pharmaceutical Co Ltd (002349) — Working Capital to Net Assets Ratio
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Working Capital to Net Assets ratio of 49.7% as of June 2026. Working capital of CN¥1.60 Billion (current assets of CN¥1.97 Billion minus current liabilities of CN¥362.18 Million) is measured against net assets of CN¥3.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Nantong Jinghua Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Nantong Jinghua Pharmaceutical Co Ltd Working Capital to Net Assets (2006–2025)
This chart shows how Nantong Jinghua Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the ratio stands at 49.7%, reflecting working capital of CN¥1.60 Billion against net assets of CN¥3.23 Billion CNY. For the complete balance sheet picture, see Nantong Jinghua Pharmaceutical Co Ltd total assets.
Annual Working Capital to Net Assets for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Nantong Jinghua Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.8% | CN¥1.63 Billion | CN¥3.15 Billion | CN¥2.03 Billion | CN¥394.79 Million | ▲ +0.5 pp |
| 2024 | 51.4% | CN¥1.52 Billion | CN¥2.96 Billion | CN¥1.84 Billion | CN¥325.58 Million | ▼ -6.6 pp |
| 2023 | 57.9% | CN¥1.62 Billion | CN¥2.80 Billion | CN¥1.99 Billion | CN¥361.51 Million | ▲ +7.1 pp |
| 2022 | 50.9% | CN¥1.33 Billion | CN¥2.62 Billion | CN¥1.73 Billion | CN¥394.63 Million | ▲ +12.3 pp |
| 2021 | 38.6% | CN¥991.83 Million | CN¥2.57 Billion | CN¥1.60 Billion | CN¥603.24 Million | ▲ +2.7 pp |
| 2020 | 35.9% | CN¥892.17 Million | CN¥2.49 Billion | CN¥1.42 Billion | CN¥528.48 Million | ▲ +10.3 pp |
| 2019 | 25.5% | CN¥548.49 Million | CN¥2.15 Billion | CN¥1.10 Billion | CN¥554.18 Million | ▼ -2.1 pp |
| 2018 | 27.6% | CN¥744.63 Million | CN¥2.69 Billion | CN¥1.25 Billion | CN¥504.59 Million | ▼ -7.0 pp |
| 2017 | 34.7% | CN¥917.64 Million | CN¥2.65 Billion | CN¥1.26 Billion | CN¥338.48 Million | ▲ +6.2 pp |
| 2016 | 28.5% | CN¥655.31 Million | CN¥2.30 Billion | CN¥872.82 Million | CN¥217.51 Million | ▼ -6.8 pp |
| 2015 | 35.3% | CN¥787.47 Million | CN¥2.23 Billion | CN¥1.05 Billion | CN¥261.03 Million | ▼ -26.3 pp |
| 2014 | 61.5% | CN¥943.94 Million | CN¥1.53 Billion | CN¥1.22 Billion | CN¥273.76 Million | ▲ +25.9 pp |
| 2013 | 35.6% | CN¥264.22 Million | CN¥741.83 Million | CN¥521.97 Million | CN¥257.75 Million | ▼ -4.6 pp |
| 2012 | 40.2% | CN¥287.72 Million | CN¥714.87 Million | CN¥459.62 Million | CN¥171.90 Million | ▼ -34.5 pp |
| 2011 | 74.7% | CN¥475.34 Million | CN¥636.30 Million | CN¥593.66 Million | CN¥118.32 Million | ▼ -8.8 pp |
| 2010 | 83.5% | CN¥454.56 Million | CN¥544.45 Million | CN¥512.97 Million | CN¥58.41 Million | ▲ +51.2 pp |
| 2009 | 32.3% | CN¥44.30 Million | CN¥137.11 Million | CN¥123.92 Million | CN¥79.62 Million | ▲ +12.5 pp |
| 2008 | 19.8% | CN¥23.54 Million | CN¥118.66 Million | CN¥96.74 Million | CN¥73.20 Million | ▲ +31.7 pp |
| 2007 | -11.9% | CN¥-10.93 Million | CN¥91.86 Million | CN¥92.26 Million | CN¥103.19 Million | ▲ +45.4 pp |
| 2006 | -57.3% | CN¥-40.13 Million | CN¥70.00 Million | CN¥75.92 Million | CN¥116.05 Million | — |